Anders Ullén Selected Research

Radium-223

1/2023	Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden.
1/2021	Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Ullén Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 02/2002
18	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2005
14	Carcinoma (Carcinomatosis) 09/2023 - 07/2013
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 09/2008
5	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2021
4	Disease Progression 09/2023 - 09/2011
3	Non-Muscle Invasive Bladder Neoplasms 12/2022 - 01/2022
2	Pathologic Constriction (Stenosis) 12/2022 - 10/2021
2	Urinary Tract Infections (Urinary Tract Infection) 12/2022 - 01/2022
2	Neutropenia 01/2019 - 12/2015
2	Circulating Neoplastic Cells 01/2019 - 11/2018
2	Febrile Neutropenia 01/2019 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2014 - 09/2011
1	Bone Fractures (Bone Fracture) 01/2023
1	Urologic Neoplasms (Urological Cancer) 01/2023
1	Thromboembolism 12/2022
1	Incisional Hernia 12/2022
1	Nocturia 10/2022
1	Diarrhea 01/2022
1	Hyponatremia 01/2019
1	Fatigue 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Microsatellite Instability 11/2018
1	Pain (Aches) 01/2018
1	Thrombocytopenia (Thrombopenia) 12/2015
1	Ovarian Neoplasms (Ovarian Cancer) 12/2015
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2007
1	Bone Resorption 01/2005

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
6	PlatinumIBA 09/2023 - 08/2016
5	avelumabIBA 09/2023 - 01/2020
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2013
4	vinflunineIBA 01/2020 - 08/2016
4	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 07/2010
4	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 01/2016
4	AndrogensIBA 01/2018 - 01/2005
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 07/2010
2	Radium-223IBA 01/2023 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2020
2	Gemcitabine FDA Link 01/2020 - 01/2020
2	Zoledronic Acid (Zometa)FDA Link 01/2017 - 01/2005
2	melflufenIBA 01/2016 - 12/2015
2	Docetaxel (Taxotere)FDA Link 08/2015 - 01/2005
1	Immunoconjugates (Immunoconjugate)IBA 12/2023
1	pembrolizumabIBA 12/2023
1	Immune Checkpoint InhibitorsIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Alkaline PhosphataseIBA 01/2021
1	LigandsIBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	enzalutamideIBA 01/2019
1	abirateroneIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	cabazitaxel FDA Link 01/2018
1	Interleukin-2 (IL2)IBA 01/2017
1	Abiraterone AcetateIBA 08/2016
1	CarbonIBA 08/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	Alkylating AgentsIBA 12/2015
1	AminopeptidasesIBA 12/2015
1	Melphalan (Alkeran)FDA LinkGeneric 12/2015
1	Peptide Hydrolases (Proteases)FDA Link 12/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2014
1	Bevacizumab (Avastin)FDA Link 09/2011
1	Sunitinib (Sutent)FDA Link 09/2011
1	InterferonsIBA 09/2011
1	Arsenic Trioxide (Trisenox)FDA Link 01/2007
1	Cytostatic AgentsIBA 01/2005
1	Hormones (Hormone)IBA 01/2005
1	Diphosphonates (Bisphosphonates)IBA 01/2005
1	Therapeutic UsesIBA 01/2005
1	Monoclonal AntibodiesIBA 02/2002
1	AntibodiesIBA 02/2002

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2024 - 09/2008
12	Therapeutics 01/2023 - 01/2005
10	Cystectomy 01/2023 - 06/2012
10	Castration 01/2023 - 08/2015
8	Radiotherapy 12/2022 - 02/2002
7	Neoadjuvant Therapy 12/2022 - 06/2012
4	Brachytherapy 10/2022 - 01/2015
2	Immunotherapy 01/2022 - 07/2019
1	Nephroureterectomy 01/2024
1	Urinary Diversion (Ileal Conduit) 01/2023
1	Adjuvant Chemotherapy 04/2022
1	Aftercare (After-Treatment) 10/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2015